ロード中...
Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
Recently, a CTLA-4 antibody and BRAF inhibitors showed survival benefits in advance melanoma treatment. The documentation of immune infiltrates in melanomas early during BRAF inhibitor therapy provides a scientific rationale for combination therapy with both treatments with possible synergistic bene...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489773/ https://ncbi.nlm.nih.gov/pubmed/23189245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19865 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|